Tag: Watchman FLX

CRT 2022: SURPASS registry shows low rate of adverse events associated...

Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientific) left atrial appendage closure (LAAC) demonstrated a low rate of...

Next-generation Watchman LAAC device gains US FDA approval

Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman FLX left atrial appendage closure (LAAC) device. The device is...